Achillion Pharmaceuticals (ACHN) Prices 15M Shares at $8.40

February 22, 2013 6:41 AM EST Send to a Friend
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) priced an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $8.40 per share. The net proceeds to Achillion from the sale of the shares, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $118.5 million. The offering is expected to close on February 27, 2013, subject to customary closing conditions. Citigroup and Leerink Swann LLC are acting as joint book-running managers, and JMP Securities LLC, Piper Jaffray & Co. and Wells Fargo Securities, LLC are acting as co-managers for the offering.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Equity Offerings

Related Entities

Piper Jaffray, Citi, JMP Securities, Wells Fargo

Add Your Comment